Views & Analysis The patient voice: A call to action On December 13th 2016 the 21st Century Cures Act (Cures Act) was signed into law in the US.
Views & Analysis FDA’s Califf embraces 21st Century Cures – but questions rem... Yesterday the outgoing President of the United States Barack Obama signed into law the 21st Century Cures Act, which has been called the most momentous health legislation in the country since t
Views & Analysis Digital health round-up – Fitbit’s smartwatch acquisition A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
